HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estimation of unit risk for coke oven emissions.

Abstract
In 1984, based on epidemiological data on cohorts of coke oven workers, USEPA estimated a unit risk for lung cancer associated with continuous exposure from birth to 1 microgram/m3 of coke oven emissions, of 6.2 x 10(-4). This risk assessment was based on information on the cohorts available through 1966. Follow-up of these cohorts has now been extended to 1982 and, moreover, individual job histories, which were not available in 1984, have been constructed. In this study, lung cancer mortality in these cohorts of coke oven workers with extended follow-up was analyzed using standard techniques of survival analysis and a new approach based on the two stage clonal expansion model of carcinogenesis. The latter approach allows the explicit consideration of detailed patterns of exposure of each individual in the cohort. The analyses used the extended follow-up data through 1982 and the detailed job histories now available. Based on these analyses, the best estimate of unit risk is 1.5 x 10(-4) with 95% confidence interval = 1.2 x 10(-4)-1.8 x 10(-4).
AuthorsS H Moolgavkar, E G Luebeck, E L Anderson
JournalRisk analysis : an official publication of the Society for Risk Analysis (Risk Anal) Vol. 18 Issue 6 Pg. 813-25 (Dec 1998) ISSN: 0272-4332 [Print] United States
PMID9972584 (Publication Type: Journal Article)
Chemical References
  • Air Pollutants, Occupational
  • Coke
Topics
  • Aged
  • Air Pollutants, Occupational (adverse effects)
  • Cohort Studies
  • Coke (adverse effects)
  • Humans
  • Likelihood Functions
  • Lung Neoplasms (mortality)
  • Male
  • Occupational Diseases (mortality)
  • Occupational Exposure
  • Pennsylvania (epidemiology)
  • Risk Assessment
  • United States
  • United States Environmental Protection Agency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: